Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(4.66)
# 180
Out of 5,124 analysts
19
Total ratings
66.67%
Success rate
38.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintains: Buy | $60 → $90 | $67.78 | +32.78% | 2 | Dec 19, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $32 → $37 | $26.70 | +38.58% | 1 | Dec 15, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $35 → $50 | $31.82 | +57.13% | 1 | Dec 15, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $46 → $60 | $19.20 | +212.50% | 2 | Dec 8, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $50 → $60 | $40.05 | +49.81% | 4 | Dec 3, 2025 | |
| PEPG PepGen | Maintains: Buy | $18 → $20 | $6.42 | +211.53% | 3 | Nov 13, 2025 | |
| RNA Avidity Biosciences | Downgrades: Neutral | $87 → $72 | $72.15 | -0.21% | 2 | Oct 27, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $4.63 | +418.36% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $0.73 | +2,651.03% | 1 | Sep 30, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $5.04 | +177.78% | 1 | Aug 15, 2025 |
Structure Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $60 → $90
Current: $67.78
Upside: +32.78%
ACADIA Pharmaceuticals
Dec 15, 2025
Maintains: Buy
Price Target: $32 → $37
Current: $26.70
Upside: +38.58%
Stoke Therapeutics
Dec 15, 2025
Maintains: Buy
Price Target: $35 → $50
Current: $31.82
Upside: +57.13%
Dyne Therapeutics
Dec 8, 2025
Maintains: Buy
Price Target: $46 → $60
Current: $19.20
Upside: +212.50%
Maze Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $50 → $60
Current: $40.05
Upside: +49.81%
PepGen
Nov 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $6.42
Upside: +211.53%
Avidity Biosciences
Oct 27, 2025
Downgrades: Neutral
Price Target: $87 → $72
Current: $72.15
Upside: -0.21%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $4.63
Upside: +418.36%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $0.73
Upside: +2,651.03%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $5.04
Upside: +177.78%